Patent and trademark assets related to absorbable surgical adhesives and sealants owned by Cohera Medical Inc® to sell on February 25, 2019 in private auction

Mon, 2/11/2019 - 3:00PM — KRISTI L. STATHIS

Ocean Tomo Transactions has been retained to conduct a private auction for the global patent portfolio and trademark assets related to absorbable surgical adhesives and sealants owned by Cohera Medical Inc®.

Ocean Tomo Transactions announced the private auction of patent and trademark assets related to absorbable surgical adhesives and sealants by Cohera Medical Inc® to sell on February 25, 2019.

Ocean Tomo Transactions has been retained by DCI Assignments, LLC, the Assignee of Cohera pursuant to an Assignment for the Benefit of Creditors, to conduct a private auction of the Cohera Medical Inc® absorbable surgical adhesives and sealants global patents, open applications and trademarks. The sale is by order the Chancery Court for the State of Delaware.

Subject to any approval that may be required by the Chancery Court for the State of Delaware in connection with the Assignment for the Benefit of Creditors of Cohera® , the highest bid as of February 25, 2019 (Midnight, PST) in the private auction, will acquire the intellectual property assets for the formulation, delivery device and methods covered by the Cohera surgical adhesive and sealants intellectual property.

Marketed by Cohera under the tradename TissuGlu®, the practice of the art disclosed in the patents resulted in the first 100% synthetic internal surgical adhesive approved for sale in the United States. TissuGlu, designed to meet a surgeon’s need for a strong, biocompatible and easy-to-use surgical adhesive, is an alternative to the use of postoperative fluid collection drains in mastectomy surgeries. It was also approved in the US for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in abdominoplasty; TissuGlu passed all biocompatibility testing as a Class III permanent implant.

With the market for surgical drains projected to rise from it’s estimated 2018 value of $1.90 billion USD to an estimated value of $2.64 billion USD by 2026, the acquirer of this portfolio of issued patents, pending applications and trademarks will have intellectual property assets with both early priority dates and important open applications in the areas of hydrophilic adhesives, pressure sensitive adhesives, spray and drop dispenser technologies.

In March of 2018, Cohera submitted a Premarket Approval Application (PMA) supplement to the U.S. Food and Drug Administration (FDA) for TissuGlu Surgical Adhesive providing new clinical evidence supporting a review by the FDA to expand the indication for TissuGlu in the US for mastectomy, pressure ulcer and other breast procedures with a combined addressable market exceeding $1 billion USD.

For further details on the portfolio, the private auction or to request an NDA for further access to a confidential presentation on this portfolio, contact Dean Becker, Adhesives or +1-251-262-0000 (PST).

The Ocean Tomo Bid-Ask Market is an open on-line platform to buy and sell patents. This market is an important step forward, both as a simplified solution for patent transactions as well as a source of information on patent pricing. The Ocean Tomo Bid-Ask Market uniquely combines the efficiency of an online platform with an experienced team of brokers fluent in both English and Mandarin. The market uses standard transaction documents and is open, transparent and free to view.

 

← PREVIOUS PAGE




Kristi L. Stathis is the Marketing Director for Ocean Tomo and serves on the board for the Center for Applied Innovation, a Chicago-based non-profit organization created to manage education, public policy outreach and related economic activity around applied technology and intellectual property (IP) rights in the State of Illinois and around the world. She is the co-creator of the Center for Applied Innovation’s Invent for Humanity™ Technology Transfer Exchange Fair, a community, marketplace and event facilitating Appropriate Technology transfer for the betterment of mankind. She also serves on the board of The Children’s Research Fund, principal benefactor of the Stanley Manne Children’s Research Institute, the research arm of Ann & Robert H. Lurie Children’s Hospital of Chicago, having served as the annual campaign co-chair in 2013.

Contact: KristiStathisBlogs@OceanTomo.com

View more posts from Kristi L. Stathis